Biohaven Topline Pivotal Trial Results for Troriluzole in Spinocerebellar Ataxia
September 23, 2024 at 8:30 AM EDT
BIOHAVEN (BHVN)
| Volume | ||
| Market Cap | ||
| 52 Week High | ||
| 52 Week Low |
Minimum 15 minutes delayed. Source: LSEG
| Volume | ||
| Market Cap | ||
| 52 Week High | ||
| 52 Week Low |
Minimum 15 minutes delayed. Source: LSEG